Mesenchymal stem cells: therapeutic outlook for stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Therapy

Background:

• Adult bone marrow-derived mesenchymal stem cells (MSCs) possess diverse functional capabilities.
• Transplantation of MSCs has demonstrated efficacy in preclinical models of neurological damage, including cerebral ischemia and spinal cord injury.
• Potential mechanisms of MSCs include cell replacement, neuroprotection, axonal growth stimulation, and promoting new blood vessel formation.

Purpose of the Study:

• To review the reparative and protective functions of MSCs in stroke models.
• To describe initial clinical studies involving intravenous MSC delivery in stroke patients.
• To offer a perspective on the future potential of MSCs in stroke therapy.

Main Methods:

• Review of existing literature on MSCs in stroke models.
• Analysis of data from initial clinical trials of intravenous MSC delivery in stroke.
• Synthesis of findings to project future research directions.

Main Results:

• MSCs demonstrate therapeutic effects in animal models of stroke, particularly after intravenous administration.
• Initial human clinical studies on intravenously delivered MSCs for stroke have been completed.
• Evidence suggests MSCs contribute to recovery through neuroprotection, axonal sprouting, and neovascularization.

Conclusions:

• Mesenchymal stem cells (MSCs) hold significant therapeutic potential for stroke recovery.
• Intravenous MSC delivery is a viable route for stroke treatment, supported by preclinical and early clinical data.
• Further research and clinical trials are essential to fully realize the prospects of MSCs in managing stroke.